AlphaMadera's AlphaVal page computes MetLife, Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag MET as undervalued, fairly valued, or overvalued.

What is MetLife, Inc.'s fair value?

Fair value for MET is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value MET?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from MET's most recent reported fundamentals.

MET - MetLife, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $95.67 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Mild

Trading 7.7% below fair value

Current Price $84.06

Bear Case $63.75 24.2% downside ($63.75 - $84.06) / $84.06 = -24.2% ROTCE 8.9% → 1.08x TBV

Fair Value $91.07 8.3% upside ($91.07 - $84.06) / $84.06 = 8.3% ROTCE 11.9% → 1.73x TBV

Bull Case $118.39 40.8% upside ($118.39 - $84.06) / $84.06 = 40.8% ROTCE 13.7% → 2.12x TBV

Adjust Assumptions

Return on Tangible Equity

11.9%

Cost of Equity

8.6%

Key Value Driver

ROTCE (11.9%) vs. cost of equity (8.6%)

Implied Market Multiple 1.9x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $95.67 from 33 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $91.07 per share.

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.

⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.

ℹ Dividend-based valuation: $46.14 (48% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.

Key Risks

Book value quality matters as much as level — check loan loss reserves
Interest rate sensitivity creates non-linear earnings surprises
Insurance reserving is actuarial, not financial — errors emerge slowly